The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.
According to the study's authors, their findings suggest that "all patients with signs or symptoms of heart failure should be considered for rhythm control therapy within a year of being diagnosed with AFib."
A new analysis reveals that acute MI and ischemic stroke are a part of the clinical landscape of COVID-19 and highlights the need for vaccination against the virus.
The funds are expected to go toward bringing in new employees and making other key additions as the company ramps up production of its flagship platform.
Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.
